Profil
Michael W.
Stevenson worked as Senior Director-Medical Affairs at FORUM Pharmaceuticals, Inc. from 2013 to 2015.
Prior to that, he was Executive Director-Medical Affairs at AMAG Pharmaceuticals, Inc. from 2008 to 2012.
He also worked as Vice President-Medical Affairs at Akcea Therapeutics, Inc. Dr. Stevenson received his undergraduate degree from Duquesne University of The Holy Spirit and his doctorate degree from Louisiana State University.
Ehemalige bekannte Positionen von Michael W. Stevenson
| Unternehmen | Position | Ende |
|---|---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2015 |
| AMAG PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2012 |
| AKCEA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Michael W. Stevenson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Duquesne University of The Holy Spirit
Duquesne University of The Holy Spirit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Louisiana State University
Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
















